China’s Strategic Drive in Brain-Computer Interface Innovation
Over the past several decades, coordinated investment at both central and local levels has propelled China’s research in Brain-Computer Interfaces (BCIs) from niche experimentation into a strategic pillar of national science policy. BCIs, which interpret neural signals to enable control of devices or physical movement through thought alone, are now explicitly listed among seven cutting-edge technologies in the 14th five-year plan and its Long-range Objectives Through the Year 2035. In a recent state television segment, a para-athlete described the technology as “a manifestation of Chinese-style modernization (中国式现代化的表现).”
BCIs are inherently data-intensive systems, requiring precise calibration for individual users and contexts. While medical rehabilitation remains the dominant application—helping stroke patients regain mobility or enabling communication for those with severe motor impairments—their adaptability raises questions about military integration and privacy risks in entertainment or consumer products. Despite their potential, China’s BCI progress has received limited international coverage.
Innovation fairs across China have showcased devices capable of “双向读写” or seamless two-way brain-device communication. At the Huangpu Future City/Greater Bay Area Metaverse Innovation Demonstration Center, BCIs were presented alongside artificial general intelligence, big data, and advanced algorithms as foundational digital technologies. Such events serve dual purposes: fostering domestic collaboration and attracting foreign researchers to Chinese innovation clusters.
BCI development in China often focuses on applied engineering rather than basic research. Neuromorphic computing, in contrast, is recognized as a theoretical frontier. By mimicking neural processes, neuromorphic systems promise energy-efficient computation for AI tasks. Shi Luping of Tsinghua University likens his work to “exploring a dark, unmapped ‘no man’s land’ (在漆黑的、没有地图的 ‘无人区’ 探路),” emphasizing that such exploration could yield “great changes (巨大变革)” in science and technology.
Media narratives frequently tie BCI achievements to national prestige. A 2016 BCI use in outer space was celebrated in 2023 as a world-first. At an innovation forum in Pujiang, Zhejiang Province, coverage praised China’s lead over the United States in patents and publications, framing it as evidence of emerging national strength. Researcher Li Xiaojian cautioned against foreign ventures such as Neuralink, calling them “quite radical and risky (比较激进，有潜在风险),” and pointed to domestic projects as models of responsible medical development.
Haihe Laboratories in Tianjin exemplify state-backed BCI research. Established in 2023, the Haihe Laboratory of Brain-Computer Interaction and Human-Computer Integration aligns directly with the 14th five-year plan’s emphasis on “科技自立自强” or self-reliance in science and technology. One scientist stated the goal to “achieve indigenization through self-reliance in science and technology (我们应该通过科技自立自强来实现国产化).” Their Shengong product line includes “Divine Armor (神工-神甲),” a robotic exoskeleton that normalizes stroke patients’ gait patterns, and “Brain Whisperer (神工-脑语者),” an implantable chip improving neural signal acquisition. Other innovations include a thought-controlled sixth robotic finger and diagnostic tools for depression.
The China Brain Project, launched with the 13th five-year plan in 2015, integrates neuroscience and AI under a “one body and two wings (一体两翼)” structure—advancing treatments for brain disorders while developing brain-machine intelligence. Unlike the US BRAIN Initiative, which prioritizes fundamental neuroscience, China’s program explicitly targets human-machine hybrid intelligence, with political incentives that extend to military-civil fusion.
China’s planning tradition ties technological priorities to binding local targets. From the seventh five-year plan in the mid-1980s, which emphasized industrial transformation through imported technology, to the 2006 Medium to Long-term Plan that revealed weaknesses in basic research investment, policy has evolved toward indigenous innovation. The 12th and 13th plans accelerated the creation of innovation hubs, though academic studies have noted distortions such as patent quantity targets leading to non-novel filings.
The current 14th five-year plan elevates basic research alongside applied projects, naming BCIs and brain-computer fusion as “关键核心技术” and setting higher R&D expenditure targets. It also calls for foundational resources like data banks and new platforms for research paper exchange. The Central Commission for Cybersecurity and Informatization has reinforced this focus, urging “strategic research deployments and scalable technological innovation in critical and advanced areas (加强 … 键前沿领域的战略研究布局和技术融通创新),” including BCIs, neuromorphic computing, and neural chips.
China’s pursuit of neurotechnology reflects both scientific ambition and political strategy. The alignment of BCIs with state narratives of modernization and self-reliance ensures sustained investment, while their dual-use potential underscores the need to consider the broader context in which these devices are developed.
